Beam Net Income vs Change In Cash Analysis

BEAM Stock  USD 30.20  2.68  9.74%   
Beam Therapeutics financial indicator trend analysis is way more than just evaluating Beam Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Beam Therapeutics is a good investment. Please check the relationship between Beam Therapeutics Net Income and its Change In Cash accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Beam Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
To learn how to invest in Beam Stock, please use our How to Invest in Beam Therapeutics guide.

Net Income vs Change In Cash

Net Income vs Change In Cash Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Beam Therapeutics Net Income account and Change In Cash. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Beam Therapeutics' Net Income and Change In Cash is -0.33. Overlapping area represents the amount of variation of Net Income that can explain the historical movement of Change In Cash in the same time period over historical financial statements of Beam Therapeutics, assuming nothing else is changed. The correlation between historical values of Beam Therapeutics' Net Income and Change In Cash is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income of Beam Therapeutics are associated (or correlated) with its Change In Cash. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Change In Cash has no effect on the direction of Net Income i.e., Beam Therapeutics' Net Income and Change In Cash go up and down completely randomly.

Correlation Coefficient

-0.33
Relationship DirectionNegative 
Relationship StrengthInsignificant

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Beam Therapeutics financial statement analysis. It represents the amount of money remaining after all of Beam Therapeutics operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Change In Cash

Most indicators from Beam Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Beam Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Beam Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
To learn how to invest in Beam Stock, please use our How to Invest in Beam Therapeutics guide.At this time, Beam Therapeutics' Selling General Administrative is very stable compared to the past year. As of the 11th of December 2024, Tax Provision is likely to grow to about 1.2 M, while Enterprise Value Over EBITDA is likely to drop (12.33).
 2021 2022 2023 2024 (projected)
Total Operating Expenses444.3M399.4M554.2M581.9M
Cost Of Revenue16.4M22.6M437.4M459.3M

Beam Therapeutics fundamental ratios Correlations

0.970.920.990.930.980.93-0.73-0.930.510.850.930.550.940.920.970.770.920.990.940.970.960.930.950.740.93
0.970.930.990.931.00.92-0.61-0.960.540.760.870.40.940.940.940.880.930.960.940.970.990.880.940.810.93
0.920.930.920.870.930.75-0.72-0.870.440.830.890.520.860.870.860.850.870.890.860.870.970.820.90.80.89
0.990.990.920.920.990.94-0.69-0.930.550.820.920.510.930.920.980.810.920.990.930.960.980.910.950.780.93
0.930.930.870.920.910.85-0.7-0.980.360.790.850.420.990.890.880.880.990.90.990.930.90.970.980.740.99
0.981.00.930.990.910.92-0.6-0.950.540.750.870.40.930.940.940.860.920.960.930.970.990.870.930.820.92
0.930.920.750.940.850.92-0.57-0.890.560.70.830.420.890.840.950.690.870.960.890.920.870.880.880.650.86
-0.73-0.61-0.72-0.69-0.7-0.6-0.570.58-0.38-0.98-0.89-0.92-0.65-0.61-0.76-0.39-0.63-0.74-0.65-0.62-0.63-0.78-0.71-0.46-0.69
-0.93-0.96-0.87-0.93-0.98-0.95-0.890.58-0.4-0.7-0.8-0.3-0.99-0.92-0.87-0.92-0.99-0.9-0.99-0.96-0.92-0.93-0.97-0.78-0.97
0.510.540.440.550.360.540.56-0.38-0.40.460.550.370.370.670.550.320.30.550.370.570.510.310.340.630.3
0.850.760.830.820.790.750.7-0.98-0.70.460.960.870.760.730.870.520.730.860.750.750.770.850.80.580.78
0.930.870.890.920.850.870.83-0.89-0.80.550.960.790.840.830.960.640.820.950.830.840.880.890.880.720.85
0.550.40.520.510.420.40.42-0.92-0.30.370.870.790.380.380.640.090.350.590.380.390.430.570.470.290.43
0.940.940.860.930.990.930.89-0.65-0.990.370.760.840.380.890.90.880.990.921.00.950.910.960.990.730.99
0.920.940.870.920.890.940.84-0.61-0.920.670.730.830.380.890.860.830.860.890.890.960.920.810.860.910.85
0.970.940.860.980.880.940.95-0.76-0.870.550.870.960.640.90.860.690.881.00.890.920.920.920.920.70.89
0.770.880.850.810.880.860.69-0.39-0.920.320.520.640.090.880.830.690.90.740.880.810.880.740.870.810.89
0.920.930.870.920.990.920.87-0.63-0.990.30.730.820.350.990.860.880.90.90.990.920.910.950.990.730.99
0.990.960.890.990.90.960.96-0.74-0.90.550.860.950.590.920.891.00.740.90.910.940.940.920.930.730.91
0.940.940.860.930.990.930.89-0.65-0.990.370.750.830.381.00.890.890.880.990.910.950.910.960.980.730.99
0.970.970.870.960.930.970.92-0.62-0.960.570.750.840.390.950.960.920.810.920.940.950.930.90.920.780.91
0.960.990.970.980.90.990.87-0.63-0.920.510.770.880.430.910.920.920.880.910.940.910.930.850.930.820.92
0.930.880.820.910.970.870.88-0.78-0.930.310.850.890.570.960.810.920.740.950.920.960.90.850.970.630.96
0.950.940.90.950.980.930.88-0.71-0.970.340.80.880.470.990.860.920.870.990.930.980.920.930.970.711.0
0.740.810.80.780.740.820.65-0.46-0.780.630.580.720.290.730.910.70.810.730.730.730.780.820.630.710.71
0.930.930.890.930.990.920.86-0.69-0.970.30.780.850.430.990.850.890.890.990.910.990.910.920.961.00.71
Click cells to compare fundamentals

Beam Therapeutics Account Relationship Matchups

Beam Therapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets156.1M451.7M1.5B1.3B1.5B794.1M
Other Current Liab10.3M91.8M112.2M68.2M122.5M67.4M
Total Current Liabilities29.1M102.3M213.4M223.6M205.6M126.7M
Total Stockholder Equity100.9M245.6M826.7M733.5M981.3M1.0B
Property Plant And Equipment Net43.2M125.4M187.0M234.1M237.8M132.8M
Net Debt(11.7M)(61.9M)(823.3M)(53.8M)(263.2M)(276.4M)
Retained Earnings(203.0M)(397.6M)(768.3M)(1.1B)(1.2B)(1.1B)
Accounts Payable7.8M6.3M7.5M9.0M1.6M1.5M
Cash37.2M162.2M965.6M232.8M435.9M311.5M
Non Current Assets Total61.6M143.4M508.8M248.8M248.7M193.3M
Non Currrent Assets Other5.0M3.1M309.1M1.9M10.9M10.3M
Cash And Short Term Investments91.8M299.7M965.6M1.1B1.2B1.2B
Common Stock Shares Outstanding51.3M46.7M64.2M70.0M77.2M56.2M
Liabilities And Stockholders Equity156.1M451.7M1.5B1.3B1.5B794.1M
Non Current Liabilities Total26.0M103.8M434.3M384.6M272.8M193.1M
Other Current Assets2.7M17.3M7.4M14.8M21.2M22.2M
Other Stockholder Equity1.9M642.6M1.6B1.8B2.2B2.3B
Total Liab55.2M206.1M647.7M608.2M478.4M319.8M
Total Current Assets94.5M308.3M965.6M1.1B1.2B1.3B
Accumulated Other Comprehensive Income16K(9K)(50K)(2.4M)604K634.2K
Common Stock73K573K684K712K816K458.7K
Other Liab418K2.5M296.5M214.9M247.1M259.5M
Net Tangible Assets(201.1M)245.6M826.7M733.5M843.5M885.7M
Other Assets18.3M18.0M14.5M14.7M16.9M14.8M
Net Invested Capital(195.4M)253.0M832.0M733.5M981.3M1.0B
Capital Stock302.1M573K684K712K816K775.2K
Non Current Liabilities Other418K2.5M34.2M13.8M3.0M2.9M
Net Working Capital65.4M206.0M1.1B869.3M1.0B610.2M
Property Plant Equipment43.2M125.4M187.0M234.1M269.3M282.7M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Beam Therapeutics is a strong investment it is important to analyze Beam Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Beam Therapeutics' future performance. For an informed investment choice regarding Beam Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Beam Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
To learn how to invest in Beam Stock, please use our How to Invest in Beam Therapeutics guide.
You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Beam Therapeutics. If investors know Beam will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Beam Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.58)
Revenue Per Share
4.273
Quarterly Revenue Growth
(0.17)
Return On Assets
(0.09)
Return On Equity
(0.18)
The market value of Beam Therapeutics is measured differently than its book value, which is the value of Beam that is recorded on the company's balance sheet. Investors also form their own opinion of Beam Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Beam Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Beam Therapeutics' market value can be influenced by many factors that don't directly affect Beam Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Beam Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Beam Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Beam Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.